Recently, in a series of tissues from 204 ccRCC patients, Wang and colleagues [187] found that high lncRNA EGFR-antisense RNA 1 (EGFR–AS1) expression levels increased two-fold the risk of death. This evidence concerns the gene EGFR and nonpapillary renal cell carcinoma.